Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 147 clinical trials
Featured trial
A randomized, double-blind, placebo-controlled multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

We are seeking participants for a clinical research study who have Atherosclerotic Cardiovascular Disease (thickening/hardening of the arteries which is caused by a buildup of plaque in the lining of an artery).This study is designed to evaluate the treatment of an investigational medication along with a well-tolerated statin therapy (lipid …

atherosclerotic cardiovascular disease
hmg-coa reductase inhibitor
stroke
  • 0 views
  • 31 May, 2022
  • 1 location
Featured trial
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.

A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.

  • 680 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

  • 1556 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Fatty Liver Disease Research Study Enrolling

Fatty Liver Disease Research Study Enrolling

  • 192 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.

Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.

  • 334 views
  • 08 Nov, 2020
  • 2 locations
Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)

This is a single arm, open label, multi centre phase III study to evaluate the efficacy and long term safety of lomitapide in paediatric patients with HoFH receiving stable LLT (including LA, when applicable) comprising of the following phases: Screening Period (starting at Week 12, i.e. ≤12 weeks prior to …

  • 0 views
  • 26 Apr, 2022
  • 10 locations
Italian Digital Primary Cardiovascular Prevention Study (CV-PREVITAL)

The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted …

Accepts healthy volunteers
  • 0 views
  • 27 Jul, 2022
  • 8 locations
Cascade Genetic Testing of Familial Hypercholesterolemia (CATCH)

Familial hypercholesterolemia (FH) is a frequent genetic disorder (1/200) associated with an increased risk of early-onset myocardial infarction. To improve detection and treatment of patient

myocardial infarction
cardiovascular disease
genetic analysis
genetic disorder
  • 5 views
  • 03 Jun, 2022
Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia (CHEETAH)

This study evaluates plaque burden and characteristics in early-treated FH patients compared to late-treated FH patients and healthy individuals.

Accepts healthy volunteers
  • 0 views
  • 10 May, 2022
  • 1 location
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) (Gateway)

Participants with documented homozygous familial hypercholesterolemia (HoFH) who have provided informed consent will receive 2 open-label doses of ARO-ANG3 and be evaluated for safety and

  • 0 views
  • 28 Jul, 2022
  • 6 locations